Asahi Kasei Medical is the core operating company of the Asahi Kasei Group for leukocyte reduction and virus removal filter operations.
| Main businesses |
Sepacell™ leukocyte reduction filters and Planova™ virus removal filters |
| Home office |
1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo 101-8101 Japan |
| President |
Yutaka Shibata |
| Paid-in capital |
200 million yen |
| Shareholder |
Asahi Kasei Corporation |
 |
| (as of April 1, 2010) |
Major Products
Major Subsidiaries
| Asahi Kasei Bioprocess Europe SA/NV |
Sale of bioprocess products |
Belgium |
+32-2-526-0500 |
| Asahi Kasei Bioprocess, Inc. |
R&D, manufacture, and sale of bioprocess-related equipment; import and sale of Planova™ virus removal filters |
US |
+1-847-556-9700 |
Corporate Officers of Asahi Kasei Medical
| Yutaka Shibata |
President & Representative Director
Presidential Executive Officer |
| Naoyuki Ohya |
Director
Primary Executive Officer |
| Toshio Asano |
Director |
| Yukio Domon |
Corporate Auditor |
| Hiroki Ideguchi |
Corporate Auditor |
 |
| (as of June 16, 2011) |